Bioton S.a.
BIO.WA · WSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | PLN 380 | PLN 350 | PLN 314 | PLN 248 |
| - Cash | PLN 2 | PLN 1 | PLN 3 | PLN 7 |
| + Debt | PLN 43 | PLN 46 | PLN 50 | PLN 57 |
| Enterprise Value | PLN 422 | PLN 395 | PLN 361 | PLN 298 |
| Revenue | PLN 73 | PLN 80 | PLN 66 | PLN 78 |
| % Growth | -9% | 21.7% | -15.5% | – |
| Gross Profit | PLN 27 | PLN 26 | PLN 14 | PLN 22 |
| % Margin | 37.1% | 33% | 21% | 28.1% |
| EBITDA | PLN 17 | PLN 15 | PLN 5 | PLN 13 |
| % Margin | 23.5% | 19.2% | 8.2% | 16.1% |
| Net Income | PLN 4 | PLN 3 | -PLN 6 | -PLN 4 |
| % Margin | 5.8% | 4.1% | -8.9% | -5.7% |
| EPS Diluted | 0.049 | 0.038 | -0.068 | -0.052 |
| % Growth | 29.4% | 155.9% | -30.3% | – |
| Operating Cash Flow | PLN 2 | PLN 10 | PLN 6 | PLN 12 |
| Capital Expenditures | -PLN 0 | -PLN 3 | -PLN 4 | -PLN 2 |
| Free Cash Flow | PLN 2 | PLN 7 | PLN 2 | PLN 10 |